Podcasts
In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic...
In our conversation, Sa’ad gives us an overview of how his interest in philosophy led to his involvement with plant...
In this conversation, we discuss some critical points such as how he managed to heal himself through the use of...
In our conversation, we discuss some of Zoe’s formative experiences in the creative arts which led her down the path...
In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a...
In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us...
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take...
In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss...
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused...
In our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject matters such as how technology...